Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019 06 13; 380(24):2295-2306.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.